KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2025)

Amneal Pharmaceuticals has reported Goodwill & Intangibles over the past 9 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $1.2 billion for Q4 2025, down 12.85% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 12.85% YoY), and the annual figure for FY2025 was $1.2 billion, down 12.85%.
  • Goodwill & Intangibles for Q4 2025 was $1.2 billion at Amneal Pharmaceuticals, down from $1.2 billion in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for AMRX hit a ceiling of $1.8 billion in Q2 2021 and a floor of $1.2 billion in Q4 2025.
  • Median Goodwill & Intangibles over the past 5 years was $1.6 billion (2023), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 99.36% in 2021 and later decreased 14.12% in 2025.
  • Amneal Pharmaceuticals' Goodwill & Intangibles stood at $1.8 billion in 2021, then fell by 3.69% to $1.7 billion in 2022, then fell by 12.15% to $1.5 billion in 2023, then decreased by 10.69% to $1.3 billion in 2024, then decreased by 12.85% to $1.2 billion in 2025.
  • The last three reported values for Goodwill & Intangibles were $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.